- Home
- KITT vs RNXT Comparison
KITT vs RNXT Comparison
Compare KITT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KITT
- RNXT
- Stock Information
- Founded
- KITT 2014
- RNXT 2012
- Country
- KITT United States
- RNXT United States
- Employees
- KITT N/A
- RNXT N/A
- Industry
- KITT Industrial Machinery/Components
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- KITT Industrials
- RNXT Health Care
- Exchange
- KITT Nasdaq
- RNXT Nasdaq
- Market Cap
- KITT 37.7M
- RNXT 44.6M
- IPO Year
- KITT N/A
- RNXT 2021
- Fundamental
- Price
- KITT $1.01
- RNXT $1.27
- Analyst Decision
- KITT
- RNXT Strong Buy
- Analyst Count
- KITT 0
- RNXT 2
- Target Price
- KITT N/A
- RNXT $7.25
- AVG Volume (30 Days)
- KITT 1.9M
- RNXT 118.6K
- Earning Date
- KITT 08-12-2025
- RNXT 08-14-2025
- Dividend Yield
- KITT N/A
- RNXT N/A
- EPS Growth
- KITT N/A
- RNXT N/A
- EPS
- KITT N/A
- RNXT N/A
- Revenue
- KITT $1,508,374.00
- RNXT $240,000.00
- Revenue This Year
- KITT $2,936.06
- RNXT $3,104.65
- Revenue Next Year
- KITT N/A
- RNXT $301.89
- P/E Ratio
- KITT N/A
- RNXT N/A
- Revenue Growth
- KITT N/A
- RNXT N/A
- 52 Week Low
- KITT $0.82
- RNXT $0.75
- 52 Week High
- KITT $6.04
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- KITT 49.85
- RNXT 45.64
- Support Level
- KITT $0.95
- RNXT $1.23
- Resistance Level
- KITT $1.15
- RNXT $1.35
- Average True Range (ATR)
- KITT 0.09
- RNXT 0.06
- MACD
- KITT -0.00
- RNXT -0.01
- Stochastic Oscillator
- KITT 23.08
- RNXT 23.53
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.